AMSA Pharm-free Scorecard 2016
Liquid error: undefined method `respond_to_missing?' for #<Liquid::Strainer:0x00000006f6a490> University of Missouri-Kansas City School of Medicine
City: Kansas City State: MO
Links:

Updates: This institution's COI policies were evaluated on May- 2-2014.

This institution has indicated their policies have not changed since they were evaluated for 2014 Scorecard.

Gifts pie3

All gifts are prohibited.

[Domain Location: Policy 1, p 3]
Meals pie2

All meals directly provided by industry are prohibited, but there is no explicit ban on meals at CME events.

[Domain Location: Policy 1, p 3]
Industry-funded promotional speaking relationships (not ACCME-accredited) pie2

Industry-paid speakers must disclose all financial interests to the audience.

[Domain Location: Policy 1, p 7]
Industry-support of ACCME-accredited CME pie2

ACCME accreditation and funding must go through the institution's CME office.

[Domain Location: Policy 1, p 5]
Attendance of industry-sponsored promotional events pie2

Attendance is allowed, but attendees cannot accept compensation for attending or for travel.

[Domain Location: Policy 1, p 5]
Industry-supported scholarships and awards pie2

Industry support is allowed, but there are safeguards in place, such as selection of recipients by the institution and funds are provided to the institution, not the recipient.

[Domain Location: Policy 1, pgs. 3 and 5]
Ghostwriting and honorary authorships pie2

The language is too vague to warrant a '3'; it states that covered persons are prohibited from publishing articles written or funded by industry, but then provides an allowance as long as industry participation is fully disclosed.

[Domain Location: Policy 1, p 6]
Consulting and advising relationships pie2

The policy specifies instances when consultation would require prior disclosure and approval, and most consulting arrangements with industry would appear to fall in that category.

[Domain Location: http://www.umsystem.edu/ums/rules/collected_rules/personnel/ch330/330.015_policy_on_conflict_of_interest]
Access of pharmaceutical sales representatives pie1

The policy does not substantially limit access. While pharmaceutical sales representatives may not 'enter clinical areas of the institution' they are allowed to meet with a covered person if they are registered with the institution's purchasing department

[Domain Location: Policy 1, p 4]
Access of medical device representatives pie3

Medical device representatives are permitted access to patient care areas to provide in-service training or assistance on already purchased projects or to assist covered persons to evaluate new industry products before purchasing them. This must take plac

[Domain Location: Policy 1, p 4]
Conflict of interest disclosure pie2

Disclosure of financial relationships that constitute a COI is required internally and during industry funded continuing medical education presentations, but there is no requirement of disclosure to trainees.

[Domain Location: Policy 1, pgs. 5-7]
COI curriculum pie2

A limited COI curriculum in the form of required training about COI for faculty and students is required by the institution. The curriculum is presented to students through PowerPoint slides, syllabus, small group discussions, large group didactic discuss

[Domain Location: Policy 1, p 7]
Extension of COI policies to community affiliates pie3

The policy applies to all faculty, employees and trainees when they are 'present at property or facilities owned, leased or operated by the institution or at activities primarily sponsored by the institution.'

[Domain Location: Policy 1, pgs. 1-2]
Enforcement and Sanctions of Policies pie3

There is a party responsible for general oversight (via a compliance concern call line that goes to a specific person) to ensure compliance with COI policies and there are sanctions for noncompliance.

[Domain Location: Policy 1, p 4-5]
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior